Menü
sharewise sharewise
Einloggen
Registrieren
Einloggen
Registrieren
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

EQS-News: Nagarro SE posts 23.7% YoY revenue growth in Q1 2023, 22.9% in constant currency: https://upload.wikimedia.org/wikipedia/commons/0/0a/Nagarro_Horizontal_Light_400x100px_300dpi.png
EQS-News: Nagarro SE posts 23.7% YoY revenue growth in Q1 2023, 22.9% in constant currency
EQS-News: Nagarro SE posts 23.7% YoY revenue growth in Q1 2023, 22.9% in constant currency
eqs_en 
0 15.05.23
EQS-Adhoc: Nagarro SE: Adjustment in guidance for FY 2023: https://upload.wikimedia.org/wikipedia/commons/0/0a/Nagarro_Horizontal_Light_400x100px_300dpi.png
EQS-Adhoc: Nagarro SE: Adjustment in guidance for FY 2023
EQS-Adhoc: Nagarro SE: Adjustment in guidance for FY 2023
eqs_en 
0 12.05.23
EQS-News: Joint Venture Approved: SHOP APOTHEKE EUROPE and Galenica Create the Leading Online Pharmacy in Switzerland.: https://upload.wikimedia.org/wikipedia/commons/thumb/0/07/Shop_Apotheke_Europe_logo.svg/640px-Shop_Apotheke_Europe_logo.svg.png
EQS-News: Joint Venture Approved: SHOP APOTHEKE EUROPE and Galenica Create the Leading Online Pharmacy in Switzerland.
EQS-News: Joint Venture Approved: SHOP APOTHEKE EUROPE and Galenica Create the Leading Online Pharmacy in Switzerland.
eqs_en 
0 11.05.23
EQS-Adhoc: SHOP APOTHEKE EUROPE and GALENICA: Antitrust clearances for joint venture granted: https://upload.wikimedia.org/wikipedia/commons/thumb/0/07/Shop_Apotheke_Europe_logo.svg/640px-Shop_Apotheke_Europe_logo.svg.png
EQS-Adhoc: SHOP APOTHEKE EUROPE and GALENICA: Antitrust clearances for joint venture granted
EQS-Adhoc: SHOP APOTHEKE EUROPE and GALENICA: Antitrust clearances for joint venture granted
eqs_en 
0 11.05.23
EQS-News: MorphoSys Highlights Potential of Its Mid- to Late-Stage Oncology Pipeline at 2023 ASCO and EHA Annual Meetings: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-News: MorphoSys Highlights Potential of Its Mid- to Late-Stage Oncology Pipeline at 2023 ASCO and EHA Annual Meetings
EQS-News: MorphoSys Highlights Potential of Its Mid- to Late-Stage Oncology Pipeline at 2023 ASCO and EHA Annual Meetings
eqs_en 
0 11.05.23
EQS-News: PATRIZIA 3M 2023 financial results: Solid EBITDA growth driven by continued increase in management fees and lower net operating expenses: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24117/375px-Logo_Patrizia_Immobilien_AG.svg.png
EQS-News: PATRIZIA 3M 2023 financial results: Solid EBITDA growth driven by continued increase in management fees and lower net operating expenses
EQS-News: PATRIZIA 3M 2023 financial results: Solid EBITDA growth driven by continued increase in management fees and lower net operating expenses
eqs_en 
0 11.05.23
EQS-News: CANCOM SE: Revenue and gross profit growth in the first quarter: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24051/375px-PLAN._BUILT._PERFORM..png
EQS-News: CANCOM SE: Revenue and gross profit growth in the first quarter
EQS-News: CANCOM SE: Revenue and gross profit growth in the first quarter
eqs_en 
0 11.05.23
EQS-News: GRENKE: Operating income rises – net profit in the first quarter of 2023 reduced by extraordinary currency and interest rate effects: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24105/Grenke_Logo.jpg
EQS-News: GRENKE: Operating income rises – net profit in the first quarter of 2023 reduced by extraordinary currency and interest rate effects
EQS-News: GRENKE: Operating income rises – net profit in the first quarter of 2023 reduced by extraordinary currency and interest rate effects
eqs_en 
0 11.05.23
EQS-News: 1&1 with a good start to the year : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24057/Drillisch_AG_Logo.svg.png
EQS-News: 1&1 with a good start to the year
EQS-News: 1&1 with a good start to the year
eqs_en 
0 10.05.23
EQS-News: Schaeffler AG: Schaeffler Group starts 2023 with good quarter: https://upload.wikimedia.org/wikipedia/commons/thumb/7/72/Schaeffler_logo.svg/640px-Schaeffler_logo.svg.png
EQS-News: Schaeffler AG: Schaeffler Group starts 2023 with good quarter
EQS-News: Schaeffler AG: Schaeffler Group starts 2023 with good quarter
eqs_en 
0 09.05.23
EQS-News: Krones AG: Krones made a very good start to the 2023 financial year: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23725/Krones_Logo.svg.png
EQS-News: Krones AG: Krones made a very good start to the 2023 financial year
EQS-News: Krones AG: Krones made a very good start to the 2023 financial year
eqs_en 
0 05.05.23
EQS-News: MorphoSys AG Reports First Quarter 2023 Financial Results: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-News: MorphoSys AG Reports First Quarter 2023 Financial Results
EQS-News: MorphoSys AG Reports First Quarter 2023 Financial Results
eqs_en 
0 03.05.23
EQS-News: AUTO1 Group SE: AUTO1 Group reports record gross profit in Q1 2023:
EQS-News: AUTO1 Group SE: AUTO1 Group reports record gross profit in Q1 2023
EQS-News: AUTO1 Group SE: AUTO1 Group reports record gross profit in Q1 2023
eqs_en 
0 03.05.23
EQS-Adhoc: Correction of a release from 02/05/2023, 08:10 CET/CEST - PATRIZIA SE: PATRIZIA accelerates its global growth ambitions with appointment of Asoka Wöhrmann as CEO Designate and Slava Shafir as COO: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24117/375px-Logo_Patrizia_Immobilien_AG.svg.png
EQS-Adhoc: Correction of a release from 02/05/2023, 08:10 CET/CEST - PATRIZIA SE: PATRIZIA accelerates its global growth ambitions with appointment of Asoka Wöhrmann as CEO Designate and Slava Shafir as COO
EQS-Adhoc: Correction of a release from 02/05/2023, 08:10 CET/CEST - PATRIZIA SE: PATRIZIA accelerates its global growth ambitions with appointment of Asoka Wöhrmann as CEO Designate and Slava Shafir as COO
eqs_en 
0 02.05.23
EQS-News: PATRIZIA SE: PATRIZIA accelerates its global growth ambitions with appointment of Asoka Wöhrmann as CEO Designate and Slava Shafir as COO: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24117/375px-Logo_Patrizia_Immobilien_AG.svg.png
EQS-News: PATRIZIA SE: PATRIZIA accelerates its global growth ambitions with appointment of Asoka Wöhrmann as CEO Designate and Slava Shafir as COO
EQS-News: PATRIZIA SE: PATRIZIA accelerates its global growth ambitions with appointment of Asoka Wöhrmann as CEO Designate and Slava Shafir as COO
eqs_en 
0 02.05.23
EQS-Adhoc: PATRIZIA SE: PATRIZIA accelerates its global growth ambitions with appointment of Asoka Wöhrmann as CEO Designate and Slava Shafir as COO: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24117/375px-Logo_Patrizia_Immobilien_AG.svg.png
EQS-Adhoc: PATRIZIA SE: PATRIZIA accelerates its global growth ambitions with appointment of Asoka Wöhrmann as CEO Designate and Slava Shafir as COO
EQS-Adhoc: PATRIZIA SE: PATRIZIA accelerates its global growth ambitions with appointment of Asoka Wöhrmann as CEO Designate and Slava Shafir as COO
eqs_en 
0 02.05.23
EQS-News: SHOP APOTHEKE EUROPE: STRONG Q1 WITH 22% SALES GROWTH AND EBITDA MARGIN IN UPPER PART OF FULL-YEAR GUIDANCE.: https://upload.wikimedia.org/wikipedia/commons/thumb/0/07/Shop_Apotheke_Europe_logo.svg/640px-Shop_Apotheke_Europe_logo.svg.png
EQS-News: SHOP APOTHEKE EUROPE: STRONG Q1 WITH 22% SALES GROWTH AND EBITDA MARGIN IN UPPER PART OF FULL-YEAR GUIDANCE.
EQS-News: SHOP APOTHEKE EUROPE: STRONG Q1 WITH 22% SALES GROWTH AND EBITDA MARGIN IN UPPER PART OF FULL-YEAR GUIDANCE.
eqs_en 
0 02.05.23
EQS-News: Invitation to MorphoSys’ First Quarter 2023 Financial Results Conference Call on May 4, 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-News: Invitation to MorphoSys’ First Quarter 2023 Financial Results Conference Call on May 4, 2023
EQS-News: Invitation to MorphoSys’ First Quarter 2023 Financial Results Conference Call on May 4, 2023
eqs_en 
0 27.04.23
EQS-News: Successful Outcome for SHOP APOTHEKE EUROPE's Annual General Meeting 2023: Approval of New CEO and Change of Corporate Name.: https://upload.wikimedia.org/wikipedia/commons/thumb/0/07/Shop_Apotheke_Europe_logo.svg/640px-Shop_Apotheke_Europe_logo.svg.png
EQS-News: Successful Outcome for SHOP APOTHEKE EUROPE's Annual General Meeting 2023: Approval of New CEO and Change of Corporate Name.
EQS-News: Successful Outcome for SHOP APOTHEKE EUROPE's Annual General Meeting 2023: Approval of New CEO and Change of Corporate Name.
eqs_en 
0 27.04.23
EQS-News: Fielmann AG: Quarterly Report and Press Release as of 31 March 2023 : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23710/Fielmann-Logo.svg.png
EQS-News: Fielmann AG: Quarterly Report and Press Release as of 31 March 2023
EQS-News: Fielmann AG: Quarterly Report and Press Release as of 31 March 2023
eqs_en 
0 27.04.23
EQS-News: CANCOM: K-Businesscom becomes part of the CANCOM Group : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24051/375px-PLAN._BUILT._PERFORM..png
EQS-News: CANCOM: K-Businesscom becomes part of the CANCOM Group
EQS-News: CANCOM: K-Businesscom becomes part of the CANCOM Group
eqs_en 
0 24.04.23
EQS-Adhoc: CANCOM SE: CANCOM SE takes over KBC Beteiligungs GmbH : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24051/375px-PLAN._BUILT._PERFORM..png
EQS-Adhoc: CANCOM SE: CANCOM SE takes over KBC Beteiligungs GmbH
EQS-Adhoc: CANCOM SE: CANCOM SE takes over KBC Beteiligungs GmbH
eqs_en 
0 24.04.23
EQS-News: Krones AG: Krones expands its capabilities in process technology with the acquisition of US company Ampco Pumps: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23725/Krones_Logo.svg.png
EQS-News: Krones AG: Krones expands its capabilities in process technology with the acquisition of US company Ampco Pumps
EQS-News: Krones AG: Krones expands its capabilities in process technology with the acquisition of US company Ampco Pumps
eqs_en 
0 21.04.23
EQS-News: Schaeffler AG: Schaeffler AGM approves dividend and appoints new Supervisory Board member: https://upload.wikimedia.org/wikipedia/commons/thumb/7/72/Schaeffler_logo.svg/640px-Schaeffler_logo.svg.png
EQS-News: Schaeffler AG: Schaeffler AGM approves dividend and appoints new Supervisory Board member
EQS-News: Schaeffler AG: Schaeffler AGM approves dividend and appoints new Supervisory Board member
eqs_en 
0 20.04.23
EQS-News: MorphoSys and Incyte Announce Five-Year Results of L-MIND Study Showed Prolonged, Durable Responses in Relapsed or Refractory DLBCL Patients Treated with Monjuvi® (tafasitamab-cxix): http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-News: MorphoSys and Incyte Announce Five-Year Results of L-MIND Study Showed Prolonged, Durable Responses in Relapsed or Refractory DLBCL Patients Treated with Monjuvi® (tafasitamab-cxix)
EQS-News: MorphoSys and Incyte Announce Five-Year Results of L-MIND Study Showed Prolonged, Durable Responses in Relapsed or Refractory DLBCL Patients Treated with Monjuvi® (tafasitamab-cxix)
eqs_en 
0 16.04.23